IGF1R and breast neoplasm: Coherent with the failure of mutant BRCA1 to suppress IGF1R gene transcription, immunohistochemical analyses of primary breast tumors derived from a cohort of 185delAG BRCA1 mutation carrier patients revealed almost twofold higher IGF1R levels than in sporadic breast tumors (24).